Home » Tag Archives: Healthcare Professionals

Tag Archives: Healthcare Professionals

Clinical trials Updates – July 2017

Last update: July 2017 Luspatercept A novel agent that increases haemoglobin by promoting erythropoiesis. More specifically it promotes the differentiation and maturation of late-stage erythrocyte precursors by acting as a ligand trap for members of the TGF-β superfamily, the increased signaling of which inhibits erythrocyte maturation. This mechanism of action ...

Read More »

Patients and Healthcare Professionals, do you report side effects?

EMA Survey on the safety of medicines and on the reporting of adverse drug reactions. Survey available at: https://ec.europa.eu/…/EMA-survey-on-reporting-adverse-drug… Tags: #patientsafety #SideEffects #pharmacovigilance.   TIF’s position: The Thalassaemia International Federation (TIF) has focused attention for some time now and continues to do so, on the need for more strengthened and coordinated actions towards ...

Read More »

Clinical trial update (April 2017)

Important Note: The latest Clinical Trial updates can be found in the link below.   April 2017 update Luspatercept (ACE-536): A novel agent that increases haemoglobin by promoting erythropoiesis (differentiation and maturation of late-stage erythrocyte precursors). Phase 2 data in adults with β-thalassaemia shows sustained increase in haemoglobin levels with ...

Read More »

Renzo Galanello Fellowship Programme 2017

OUR SPECIALIST TEAM: Prof John Porter, Supervisor Dr Perla Eleftheriou, Coordinator and many other valuable colleagues. FUNDING: A stipend of $2000 USD/month for each successful candidate, which intends to cover the successful candidate’s accommodation, daily transportation and basic living expenses. Any expenses above this amount will be the responsibility of the ...

Read More »